A federal appeals court heard arguments Wednesday in a case that could determine the future of a commonly used abortion pill, opening a line of questioning centered around the drug’s safety and what at least one judge suggested is the fallibility of national drug regulators.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,